Evidence map›Paper›PMID 29606129›Full record

Trial reportAddiction science & clinical practice2018

Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol.

Kasey Claborn, Sara Becker, Don Operario, Steve Safren, Josiah D Rich, Susan Ramsey

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Addiction science & clinical practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02907697 (Adherence Intervention for HIV-infected Drug Users), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02907697 naunknown statusnot on this map

Adherence Intervention for HIV-infected Drug Users

TypeinterventionalSponsorUniversity of Texas at AustinRan2016 to 2022Enrolled132ConditionsHIV, Substance UseArmsLife Steps-Drug Use, General Health Education
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kasey ClabornDepartment of Psychiatry, The University of Texas at Austin Dell Medical School, 1912 Speedway, Austin, TX, USA. kasey.claborn@austin.utexas.edu.
Sara BeckerDepartment of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Box G-BH, Providence, RI, 02912, USA.
Don OperarioCenter for Alcohol and Addiction Studies, Brown University School of Public Health, 121 South Main Street, Box G-121-5, Providence, RI, 02912, USA.
Steve SafrenDepartment of Psychology, University of Miami, Coral Gables, FL, USA.
Josiah D RichDepartment of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Susan RamseyDepartment of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Brown University · USUniversity of Miami · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Science/Technical CoreP2CHD041020 · NICHD · BROWN UNIVERSITY · PI ZHENCHAO QIAN · 2016 to 2026
$7.6M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
Midcareer Investigator Award in Patient Oriented ResearchK24DA022112 · NIDA · MIRIAM HOSPITAL · PI RICH, JOSIAH D · 2008 to 2017
$1.7M
Addressing psychosocial comorbidities in HIV treatment and preventionK24DA040489 · NIDA · UNIVERSITY OF MIAMI CORAL GABLES · PI SAFREN, STEVEN A · 2016 to 2020
$931k
Adherence Intervention for HIV-infected Drug UsersK23DA039037 · NIDA · UNIVERSITY OF TEXAS AT AUSTIN · PI CLABORN, KASEY R · 2015 to 2019
$919k
NIAID NIH HHS P30 AI042853NICHD NIH HHS P2C HD041020NIDA NIH HHS K23 DA039037NIDA NIH HHS K24 DA022112NIDA NIH HHS K24 DA040489NIMH NIH HHS R25 MH067127
6 · The paper itself

Abstract

backgroundHIV-infected people who use drugs (PWUD) exhibit the highest rates of non-adherence to antiretroviral therapy (ART) among people living with HIV. This contributes to poor treatment outcomes, increased morbidity and mortality, and HIV transmission. However, current interventions fail to address the unique barriers to adherence faced by this population. Life Steps is a brief, single session intervention that demonstrated increased ART adherence among HIV-infected individuals. This study protocol seeks to improve clinical practice by adapting Life Steps for HIV-infected PWUD and adding a brief motivational intervention addressing drug use. This intervention will incorporate educational, motivational, and behavioral skills components specifically aimed at improving adherence and linkage to substance use treatment among HIV-infected PWUD.

methodsThis project will consist of three phases using a mixed-methods approach. In Phase 1, qualitative interviews with HIV-infected PWUD and community providers, coupled with feedback from an expert review panel, will be used to enhance the existing Life Steps manual and interventionist training protocol. In Phase 2, the prototype will be pilot tested and qualitative exit interviews with HPWUD will identify the strengths and limitations of the intervention. Data regarding feasibility, acceptability, and barriers to delivery will guide modifications to finalize a modified Life Steps-Drug Use (LS-DU) protocol. In Phase 3, a pilot type 1 hybrid effectiveness-implementation trial will examine the effectiveness of LS-DU relative to a health education intervention control condition on ART adherence and viral load data at 1-, 3-, and 6-months. Data regarding clinic readiness for implementation and intervention sustainability potential will be collected. DISCUSSION: This protocol will adapt and evaluate an intervention to improve adherence among HIV-infected PWUD. Results of this study will provide significant data on the acceptability, initial effectiveness, and sustainability potential of an adherence intervention for a high risk and underserved population. Trial registration NCT02907697.

Indexed as

Drug MonitoringAlcohol DrinkingAnti-HIV AgentsBehavior TherapyFemaleHIV InfectionsHumansMaleMotivationPatient Education as TopicPilot ProjectsResearch DesignSubstance-Related DisordersViral LoadAnti-HIV AgentsAdherenceHIV/AIDSMixed methodsMotivational interviewProtocolSubstance use

Identifiers

PMID29606129
PMCPMC5879738
OpenAlexW2795643770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.